Randox Liquid Assayed Specific Protein Control - Level 2 (SP Control 2), Cat. no. PS2683
Published July 4, 2018 · Recall initiated: May 22, 2018
Summary
FDA records medical device Class II recall Z-2279-2018, published July 4, 2018 and initiated May 22, 2018. Recalling firm: Randox Laboratories Ltd.; Status: Terminated; Lot: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The recalling firm has confirmed that Free Kappa light chains in Liquid Assayed Specific Protein Controls increase over the shelf life of the product. This may lead to a delay in reporting Free Kappa Light Chains results, which are used as an aid in diagnosis of monoclonal gammopathy of undetermined significance and for Multiple Myeloma through review of the ratio with free lambda chains.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Randox Laboratories Ltd.
- Distributor
- Distributed to accounts in CA, IN, KS, ME, and WV, and PR. Foreign distribution to Australia, Bangladesh, Belarus, Belgium, Brazil, Cambodia, Canada, Chile, China, Colombia, Cyprus, Denmark, Dutch Caribbean, Ecuador, Egypt, El Salvador, Ethiopia, Falkland Islands, Finland, France, Georgia, Germany, Greece, Guatemala, Hong Kong, India, Iraq, Ireland, Italy, Jordan, Kenya, Saudi Arabia, Korea, Kuwait, Latvia, Lebanon, Peru, Lithuania, Macedonia, Malaysia, Malta, Mauritius, Mexico, Morocco, Myanmar, New Zealand, Norway, Pakistan, Philippines, Poland, Portugal, Qatar, Romania, Russia, Serbia, Slovakia, South Africa, Spain, Sri Lanka, Oman, Thailand, Netherlands, Turkey, United Arab Emirates, United Kingdom, Ukraine, Vietnam, and Zimbabwe.
- Lot
- All lots.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Ireland
Related recalls
- FDARX Series CYSC- Cystatin C Reagent -Intended for in vitro diagnostic (IVD) use as Randox Cystatin C assay onJuly 31, 2024
- FDAClinical Chemistry Calibration Serum (Catalog number Cal2351) that is 20x5ml lyophilized human based serumMay 15, 2024
- FDAEvidence MultiSTAT with software v 3.7-Analyzer intended for the qualitative determination of parent drugMay 15, 2024
- FDAMicroalbumin Calibrator Series (mALB CAL)-IVD used to calibrate the Microalbumin Assay Catalog Number: MA1567April 24, 2024
- FDABrilliance Big Bore Radiology 728244July 4, 2018
- FDACS-7, Model No. A4C1July 4, 2018
Questions about this recall
Was Randox Liquid Assayed Specific Protein Control - Level 2 (SP Control 2), Cat. no. PS2683 recalled?
Yes. FDA published recall Z-2279-2018 on July 4, 2018. Reported hazard: The recalling firm has confirmed that Free Kappa light chains in Liquid Assayed Specific Protein Controls increase over the shelf life of the product. This may lead to a delay in reporting Free Kappa Light Chains results, which are used as an aid in diagnosis of monoclonal gammopathy of undetermined significance and for Multiple Myeloma through review of the ratio with free lambda chains.
What should I do if I have this product?
Voluntary: Firm initiated · Letter